Elsa De La Cadena1, María Fernanda Mojica1,2,3, Nathaly Castillo1, Adriana Correa4,5, Tobias Manuel Appel1, Juan Carlos García-Betancur1, Christian José Pallares1,6, María Virginia Villegas1,6. 1. Grupo de Investigación en Resistencia Antimicrobiana y Epidemiologia Hospitalaria, Universidad El Bosque, Bogotá 110121, Colombia. 2. Department of Infectious Diseases, Case Western Reserve University, Cleveland, OH 44106-7164, USA. 3. Research Service, Louis Stokes Veterans Affairs Medical Center, Cleveland, OH 44106-7164, USA. 4. Centro Internacional de Entrenamiento e Investigaciones Médicas (CIDEIM), Cali 760031, Colombia. 5. Facultad de Ciencias Básicas, Universidad Santiago de Cali, Cali 760031, Colombia. 6. Comité de Infecciones y Vigilancia Epidemiológica, Centro Médico Imbanaco, Cali 760031, Colombia.
Abstract
BACKGROUND: The dissemination of the uropathogenic O25b-ST131 Escherichia coli clone constitutes a threat to public health. We aimed to determine the circulation of E. coli strains belonging to O25b:H4-B2-ST131 and the H30-Rx epidemic subclone causing hospital and community-acquired urinary tract infections (UTI) in Colombia. METHODS: Twenty-six nonduplicate, CTX-M group-1-producing isolates causing UTI in the hospital and community were selected for this study. RESULTS: Twenty-two E. coli isolates harboring CTX-M-15, one CTX-M-3, and three CTX-M-55 were identified. Multilocus Sequence Typing (MLST) showed a variety of sequence types (STs), among which, ST131, ST405, and ST648 were reported as epidemic clones. All the E. coli ST131 sequences carried CTX-M-15, from which 80% belonged to the O25b:H4-B2 and H30-Rx pandemic subclones and were associated with virulence factors iss, iha, and sat. E. coli isolates (23/26) were resistant to ciprofloxacin and associated with amino acid substitutions in quinolone resistance-determining regions (QRDR). We detected two carbapenem-resistant E. coli isolates, one coproducing CTX-M-15, KPC-2, and NDM-1 while the other presented mutations in ompC. Additionally, one isolate harbored the gene mcr-1. CONCLUSIONS: Our study revealed the circulation of the E. coli ST131, O25b:H4-B2-H30-Rx subclone, harboring CTX-M-15, QRDR mutations, and other resistant genes. The association of the H30-Rx subclone with sepsis and rapid dissemination warrants attention from the public health and infections control.
BACKGROUND: The dissemination of the uropathogenic O25b-ST131Escherichia coli clone constitutes a threat to public health. We aimed to determine the circulation of E. coli strains belonging to O25b:H4-B2-ST131 and the H30-Rx epidemic subclone causing hospital and community-acquired urinary tract infections (UTI) in Colombia. METHODS: Twenty-six nonduplicate, CTX-M group-1-producing isolates causing UTI in the hospital and community were selected for this study. RESULTS: Twenty-two E. coli isolates harboring CTX-M-15, one CTX-M-3, and three CTX-M-55 were identified. Multilocus Sequence Typing (MLST) showed a variety of sequence types (STs), among which, ST131, ST405, and ST648 were reported as epidemic clones. All the E. coli ST131 sequences carried CTX-M-15, from which 80% belonged to the O25b:H4-B2 and H30-Rx pandemic subclones and were associated with virulence factors iss, iha, and sat. E. coli isolates (23/26) were resistant to ciprofloxacin and associated with amino acid substitutions in quinolone resistance-determining regions (QRDR). We detected two carbapenem-resistant E. coli isolates, one coproducing CTX-M-15, KPC-2, and NDM-1 while the other presented mutations in ompC. Additionally, one isolate harbored the gene mcr-1. CONCLUSIONS: Our study revealed the circulation of the E. coli ST131, O25b:H4-B2-H30-Rx subclone, harboring CTX-M-15, QRDR mutations, and other resistant genes. The association of the H30-Rx subclone with sepsis and rapid dissemination warrants attention from the public health and infections control.
Authors: James R Johnson; Stephen B Porter; George Zhanel; Michael A Kuskowski; Erick Denamur Journal: Infect Immun Date: 2012-02-06 Impact factor: 3.441
Authors: Ritu Banerjee; Ari Robicsek; Michael A Kuskowski; Stephen Porter; Brian D Johnston; Evgeni Sokurenko; Veronika Tchesnokova; Lance B Price; James R Johnson Journal: Antimicrob Agents Chemother Date: 2013-09-30 Impact factor: 5.191
Authors: Lance B Price; James R Johnson; Maliha Aziz; Connie Clabots; Brian Johnston; Veronika Tchesnokova; Lora Nordstrom; Maria Billig; Sujay Chattopadhyay; Marc Stegger; Paal S Andersen; Talima Pearson; Kim Riddell; Peggy Rogers; Delia Scholes; Barbara Kahl; Paul Keim; Evgeni V Sokurenko Journal: mBio Date: 2013-12-17 Impact factor: 7.867
Authors: Nicole Stoesser; Anna E Sheppard; Louise Pankhurst; Nicola De Maio; Catrin E Moore; Robert Sebra; Paul Turner; Luke W Anson; Andrew Kasarskis; Elizabeth M Batty; Veronica Kos; Daniel J Wilson; Rattanaphone Phetsouvanh; David Wyllie; Evgeni Sokurenko; Amee R Manges; Timothy J Johnson; Lance B Price; Timothy E A Peto; James R Johnson; Xavier Didelot; A Sarah Walker; Derrick W Crook Journal: mBio Date: 2016-03-22 Impact factor: 7.867